Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 16, 2009 - Issue 4
209
Views
54
CrossRef citations to date
0
Altmetric
Original Article

Usefulness of labial salivary gland biopsy in familial amyloid polyneuropathy Portuguese type

, , &
Pages 232-238 | Published online: 19 Nov 2009

References

  • Andrade C. A peculiar form of peripheral neuropathy. Familial atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 1952;75:408–427.
  • Sousa A, Coelho T, Morgado R, Coutinho P. Statistical analysis of factors which may influence the duration of FAP type I. In: Costa PP, Freitas AF, Saraiva MJM, editors. Familial amyloidotic polyneuropathy and other transthyretin related disorders. Porto: Arquivos de Medicina; 1990. pp 351–355.
  • Lobato L, Beirão I, Silva M, Bravo F, Silvestre F, Guimarães S, Sousa A, Noel LH, Sequeiros J. Familial ATTR amyloidosis: microalbuminuria as a predictor of symptomatic disease and clinical nephropathy. Nephrol Dial Transplant 2003;18:532–538.
  • Sandgren O, Drugge U, Holmgren G, Sousa A. Vitreous involvement in familial amyloidotic polyneuropathy: a genealogical and genetic study. Clin Genet 1991;40:452–460.
  • Fonseca C, Ceia F, Carvalho A, Nogueira JS, Morais H, Conceição I, Sales Luis ML, Sales Luis AS. The natural history of cardiac involvement in Portuguese-type familial amyloid polyneuropathy. Rev Port Cardiol 1997;16:101–105.
  • Planté-Bordeneuve V, Lalu T, Misrahi M, Reilly MM, Adams D, Lacroix C, Said G. Genotypic-phenotypic variations in a series of 65 patients with familial amyloid polyneuropathy. Neurology 1998;51:708–714.
  • Benson MD. The molecular biology and clinical features of amyloid neuropathy. Muscle & Nerve 2007;36:411–552.
  • Saraiva MJM, Costa PP, Goodman DS. Genetic expression of a transthyretin mutation in typical and late-onset Portuguese families with familial amyloidotic polyneuropathy. Neurology 1986;36:1413–1417.
  • Nakazato M, Steen L, Holmgren G, Matsukura S, Kangawa K, Matsuo H. Structurally abnormal transthyretin causing familial amyloid polyneuropathy in Sweden. Clin Chem Acta 1987;167:341–342.
  • Ikeda S-I, Nakazato M, Ando Y, Sobue G. Familial transthyretin-type amyloid polyneuropathy in Japan clinical and genetic heterogeneity. Neurology 2002;58:1001–1007.
  • Munar-Qués M, Maria JM Saraiva. Viader-Farré C, Zabay-Becerril JM, Mulet-Ferrer J. Genetic epidemiology of familial amyloid polyneuropathy in Balearic Islands (Spain). Amyloid 2005;12:54–61.
  • Lechapt-Zalcman E, Authier FJ, Creance A, Voisin MC, Gherardi RK. Labial salivary biopsy for diagnosis of amyloid polyneuropathy. Muscle & Nerve 1999;22:105–107.
  • Hachulla E, Grateau G. Diagnostic tools for amyloidosis. Joint Bone Spine 2002;54:538–545.
  • Coutinho P, Silva AM, Lima LJ. Forty years of experience with type I amyloid neuropathy. Review of 483 cases. In: Glenner GG, Costa PP, Freitas AF, editors. Amyloid and amyloidosis. Amsterdam: Excerpta Medica; 1980. pp 88–98.
  • Sousa A, Coelho T, Barros J, Sequeiros J. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP) - type I in Póvoa do Varzim/Vila do Conde (North of Portugal). Am J Med Gen (Neurop Genetics) 1995;60:512–521.
  • Falk RH, Comenzo RL, Skinner M. The systemic amyloidosis. N Engl J Med 1997;337:898–909.
  • von Bültzingslöwen I, Sollecito TP, Fox PC, Daniels T, Jonsson R, Lockhart PB, Wray D, Brennan TM, Carrozzo M, Gandera B, Fujibayashi T, Navazesh M, Rhodus NL, Schiøt M. Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103(S1):S57–S65.
  • Eliasson l, Birkhed D, Carlén A. Feeling of dry mouth in relation to whole and minor saliva secretion rate. Arch Oral Biol 2009;54:263–267.
  • Delgado W, Arana-Chavez A, Victor E. Amyloid deposits in labial salivary glands identified by electron microscopy. J Oral Pathol Med 1997;26:51–52.
  • Guimarães A, Pinheiro AV, Leite I. Sural nerve biopsy in familial amyloidotic polyneuropathy: a morphological and morphometric polyneuropathy. In: Isobe T, Araki A, Uchino F, Kito S, Tsubura E, editors. Amyloid and amyloidosis. New York: Plenum Press; 1988. pp 493–498.
  • Gabriel CM, Howard R, Kinsella N, Lucas S, McColl I, Saldanha G, Hall SM, Hughes RAC. Prospective study of 4 the usefulness of sural nerve biopsy. J Neurol Neurosurg Psychiatry 2000;69:442–446.
  • Haagsma EB, Van Gameren II, Bijzet J, Posthumus MD, Hazemberg BPC. Familial amyloidotic polyneuropathy: long-term follow-up of abdominal fat tissue aspirate in patients with and without liver transplantation. Amyloid 2007;14:221–226.
  • Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 1995;32:45–59.
  • Selikoff IJ, Robitzek EH. Gingival biopsy for the diagnosis of generalized amyloidosis. Am J Pathol 1947;23:1099–1111.
  • Lovett DW, Cross KR, Van Allen M. The prevalence of amyloid in gingival tissue. Oral Surg Oral Med Oral Pathol 1965;20:444–448.
  • Salisbury PL, Jakoway JR. Oral amyloidosis: a late complication of multiple mieloma. Oral Surg Oral Med Oral Pathol 1983;56:48–50.
  • Biewend ML, Menke DM, Calamia KT. The spectrum of localizes amyloidosis: a case series of 20 patients and review of the literature. Amyloid 2006;13:135–142.
  • Pribitkin E, Friedman O, O'Hara B, Cunnane MF, Rosen M, Keane WM, Sataloff RT. Amyloidosis of the upper aerodigestive tract. Laryngoscope 2003;113:2095–2101.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.